Healthcare Global Enterprises Ltd (HCG) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 1002586, "name": "Health.Global", "stock_name": "Health.Global", "full_name": "Healthcare Global Enterprises Ltd", "name_url": "stocks-analysis/healthglobal", "exchange": 0, "exchangecode": "", "country_id": 34, "currency": "INR", "cmp": "570.80", "chg": -26.2, "chgp": "-4.39%", "dir": -1, "prev_price": "597.00", "mcapval": "8,162.00 Cr", "mcap": "Small Cap", "scripcode": 539787, "symbol": "HCG", "ind_name": "Hospital", "ind_code": 94, "indexname": "", "isin": "INE075I01017", "curr_date": "Feb 06", "curr_time": "", "bse_nse_vol": "4.04 lacs", "exc_status": "Active", "traded_date": "Feb 06, 2026", "traded_date_str": "2026 02 06", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/healthglobal-1002586-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0, "all_data": [] } }, "news": { "results": [ { "title": "Healthcare Global Enterprises Ltd Falls 4.09%: Debt and Losses Cloud Weekly Performance", "link": "https://www.marketsmojo.com/news/stocks-in-action/healthcare-global-enterprises-ltd-falls-409-debt-and-losses-cloud-weekly-performance-3826114", "imagepath": "", "date": "2026-02-07 13:03:47", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>2 Feb:</strong> Downgrade to Sell rating amid deteriorating fundamentals</p>\n <p><strong>2 Feb:</strong> Quality grade falls to below average with elevated debt metrics</p>\n <p><strong>5 Feb:</strong> Q3 FY26 results reveal loss despite revenue growth</p>\n <p><strong>6 Feb:</strong> Stock closes the week at Rs.567.55, down 4.09%</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.591.75</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value..." }, { "title": "Are Healthcare Global Enterprises Ltd latest results good or bad?", "link": "https://www.marketsmojo.com/news/result-analysis/are-healthcare-global-enterprises-ltd-latest-results-good-or-bad-3824911", "imagepath": "", "date": "2026-02-06 19:28:24", "description": "Healthcare Global Enterprises Ltd's latest financial results for the quarter ended December 2025 present a complex picture. The company reported consolidated net sales of ₹633.07 crores, reflecting a year-on-year growth of 13.34%. However, this growth was accompanied by a sequential decline of 2.13% compared to the previous quarter. The operating profit, excluding other income, stood at ₹109.61 crores, with an operating margin of 17.37%, which indicates a year-on-year improvement but a sequential decline of 174 basis points.\n\nA significant concern is the consolidated net profit, which turned negative at ₹-9.43 crores, representing a dramatic year-on-year decline of 235.10%. This loss is a stark reversal from the profit of ₹16.27 crores reported in the previous quarter, raising questions about the company's operational efficiency and cost management. The profit before tax also showed a concerning shift, movi..." }, { "title": "Healthcare Global Enterprises Q3 FY26: Loss-Making Quarter Raises Concerns Despite Revenue Growth", "link": "https://www.marketsmojo.com/news/result-analysis/healthcare-global-enterprises-q3-fy26-loss-making-quarter-raises-concerns-despite-revenue-growth-3824239", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/HealthcareGloba_quaterlyResult_3824239.png", "date": "2026-02-05 22:03:08", "description": "Healthcare Global Enterprises Ltd., India's leading oncology-focused hospital chain, reported a consolidated net loss of ₹9.43 crores for Q3 FY26, marking a dramatic reversal from the ₹16.27 crores profit posted in the previous quarter. This represents a sequential decline of 157.96% and a year-on-year contraction of 235.10%, sending alarm bells through investor circles. The stock, trading at ₹595.80 with a market capitalisation of ₹8,330 crores, has declined 2.11% following the results announcement, reflecting investor disappointment with the company's profitability trajectory." }, { "title": "Are Healthcare Global Enterprises Ltd latest results good or bad?", "link": "https://www.marketsmojo.com/news/result-analysis/are-healthcare-global-enterprises-ltd-latest-results-good-or-bad-3822944", "imagepath": "", "date": "2026-02-05 19:31:47", "description": "Healthcare Global Enterprises Ltd's latest financial results for the quarter ended September 2025 present a mixed picture. The company reported consolidated net sales of ₹646.85 crores, reflecting a year-on-year growth of 16.86%, which is an improvement from the previous year's growth rate of 13.68%. This performance indicates a strong revenue trajectory, driven by increased patient footfall and enhanced service offerings across its network of cancer care centres.\n\nHowever, the consolidated net profit for the same period was ₹16.27 crores, which represents a decline of 9.56% compared to the previous year, contrasting sharply with the profit growth of 32.57% seen in the same quarter of the prior year. This decline raises concerns about the company's profitability despite the revenue growth.\n\nThe operating margin, excluding other income, improved to 19.11%, up from 18.51% in the previous year, indicating some..." }, { "title": "Healthcare Global Enterprises Ltd Downgraded to Sell Amid Weak Fundamentals and Elevated Debt", "link": "https://www.marketsmojo.com/news/stock-recommendation/healthcare-global-enterprises-ltd-downgraded-to-sell-amid-weak-fundamentals-and-elevated-debt-3815813", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/HealthcareGloba_mojoScore_3815813.png", "date": "2026-02-02 08:44:02", "description": "Healthcare Global Enterprises Ltd has been downgraded from a Hold to a Sell rating following a comprehensive reassessment of its quality, valuation, financial trends, and technical indicators. Despite a respectable long-term stock return, the company’s deteriorating fundamentals and high leverage have raised concerns among analysts, prompting a cautious stance on the hospital sector player." }, { "title": "Healthcare Global Enterprises Ltd Downgraded as Quality Parameters Deteriorate", "link": "https://www.marketsmojo.com/news/stocks-in-action/healthcare-global-enterprises-ltd-downgraded-as-quality-parameters-deteriorate-3815239", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/HealthcareGloba_qualitydot_3815239.png", "date": "2026-02-02 08:00:35", "description": "Healthcare Global Enterprises Ltd, a key player in the hospital sector, has seen its quality grading downgraded from average to below average, reflecting a notable deterioration in its business fundamentals. Despite impressive long-term returns, recent financial metrics and leverage ratios have raised concerns among analysts, prompting a downgrade to a Sell rating with a Mojo Score of 44.0 as of 1 February 2026." }, { "title": "Healthcare Global Enterprises Ltd is Rated Hold", "link": "https://www.marketsmojo.com/news/stock-recommendation/healthcare-global-enterprises-ltd-is-rated-hold-3809219", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/HealthcareGloba_mojoScore_3809219.png", "date": "2026-01-29 10:10:47", "description": "Healthcare Global Enterprises Ltd is rated 'Hold' by MarketsMOJO, a rating that was last updated on 24 November 2025. While this rating change occurred several weeks ago, the analysis and financial metrics discussed here reflect the stock’s current position as of 29 January 2026, providing investors with an up-to-date perspective on the company’s standing." }, { "title": "Healthcare Global Enterprises Ltd is Rated Hold", "link": "https://www.marketsmojo.com/news/stock-recommendation/healthcare-global-enterprises-ltd-is-rated-hold-3784401", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/HealthcareGloba_mojoScore_3784401.png", "date": "2026-01-07 10:10:39", "description": "Healthcare Global Enterprises Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 24 Nov 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 07 January 2026, providing investors with an up-to-date view of its fundamentals, returns, and overall outlook." }, { "title": "Healthcare Global Enterprises Ltd is Rated Hold", "link": "https://www.marketsmojo.com/news/stock-recommendation/healthcare-global-enterprises-ltd-is-rated-hold-3771946", "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/HealthcareGloba_mojoScore_3771946.png", "date": "2025-12-27 10:10:04", "description": "Healthcare Global Enterprises Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 24 November 2025. However, the analysis and financial metrics presented here reflect the stock's current position as of 27 December 2025, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing." } ], "total": 222, "sid": "1002586", "stock_news_url": "https://www.marketsmojo.com/news/healthcare-global-enterprises-1002586" }, "announcements": [ { "caption": "Announcement under Regulation 30 (LODR)-Change in Management", "datetime": "05-Feb-2026", "details": "This is to inform that the Board of Directors of the Company at its meeting held on February 05 2026 has approved the appointment of Dr Naveen R Nagar as Head - Clinical Strategy of the Company.", "source": "BSE" }, { "caption": "Unaudited Financial Results Of The Company (Standalone And Consolidated) For The Quarter And Nine Months Ended December 31 2025.", "datetime": "05-Feb-2026", "details": "Approval of Unaudited Financial Results of the Company (Standalone and Consolidated) for the quarter and nine months ended December 31 2025", "source": "BSE" }, { "caption": "Board Meeting Outcome for Outcome Of Board Meeting", "datetime": "05-Feb-2026", "details": "This is to inform that the Board of Directors of the Company at its meeting held on February 05 2026 has inter alia considered and approved the following agenda: 1. Unaudited Financial Results of the Company (Standalone and Consolidated) for the quarter and nine months ended December 31 2025. 2. Introduction and adoption of HCG Employee Stock Option Scheme 2026 to grant Employee Stock Options to Eligible Employees of the Company and its subsidiaries subject to approval of Members of the Company and other requisite regulatory or statutory approvals as may be applicable. Detailed disclosure in this regard shall be made separately. 3. Appointment of Dr. Naveen R. Nagar as Head - Clinical Strategy and Mr. Pankaj Gautam as Chief Information Officer designated as Senior Management Personnel of the Company. Detailed disclosure in this regard shall be made separately.", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "No <strong>Dividend</strong> history available", "data": [] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

2 Feb: Downgrade to Sell rating amid deteriorating fundamentals

2 Feb: Quality grade falls to below average with elevated debt metrics

5 Feb: Q3 FY26 results reveal loss despite revenue growth

6 Feb: Stock closes the week at Rs.567.55, down 4.09%

Week Open

Rs.591.75

Week Close

Read full news article

Are Healthcare Global Enterprises Ltd latest results good or bad?

2026-02-06 19:28:24

Healthcare Global Enterprises Ltd's latest financial results for the quarter ended December 2025 present a complex picture. The company reported consolidated net sales of ₹633.07 crores, reflecting a year-on-year growth of 13.34%. However, this growth was accompanied by a sequential decline of 2.13% compared to the previous quarter. The operating profit, excluding other income, stood at ₹109.61 crores, with an operating margin of 17.37%, which indicates a year-on-year improvement but a sequential decline of 174 basis points. A significant concern is the consolidated net profit, which turned negative at ₹-9.43 crores, representing a dramatic year-on-year decline of 235.10%. This loss is a stark reversal from the profit of ₹16.27 crores reported in the previous quarter, raising questions about the company's operational efficiency and cost management. The profit before tax also showed a concerning shift, movi...

Read full news article

Healthcare Global Enterprises Q3 FY26: Loss-Making Quarter Raises Concerns Despite Revenue Growth

2026-02-05 22:03:08

Healthcare Global Enterprises Ltd., India's leading oncology-focused hospital chain, reported a consolidated net loss of ₹9.43 crores for Q3 FY26, marking a dramatic reversal from the ₹16.27 crores profit posted in the previous quarter. This represents a sequential decline of 157.96% and a year-on-year contraction of 235.10%, sending alarm bells through investor circles. The stock, trading at ₹595.80 with a market capitalisation of ₹8,330 crores, has declined 2.11% following the results announcement, reflecting investor disappointment with the company's profitability trajectory.

Read full news article

Are Healthcare Global Enterprises Ltd latest results good or bad?

2026-02-05 19:31:47

Healthcare Global Enterprises Ltd's latest financial results for the quarter ended September 2025 present a mixed picture. The company reported consolidated net sales of ₹646.85 crores, reflecting a year-on-year growth of 16.86%, which is an improvement from the previous year's growth rate of 13.68%. This performance indicates a strong revenue trajectory, driven by increased patient footfall and enhanced service offerings across its network of cancer care centres. However, the consolidated net profit for the same period was ₹16.27 crores, which represents a decline of 9.56% compared to the previous year, contrasting sharply with the profit growth of 32.57% seen in the same quarter of the prior year. This decline raises concerns about the company's profitability despite the revenue growth. The operating margin, excluding other income, improved to 19.11%, up from 18.51% in the previous year, indicating some...

Read full news article

Healthcare Global Enterprises Ltd Downgraded to Sell Amid Weak Fundamentals and Elevated Debt

2026-02-02 08:44:02

Healthcare Global Enterprises Ltd has been downgraded from a Hold to a Sell rating following a comprehensive reassessment of its quality, valuation, financial trends, and technical indicators. Despite a respectable long-term stock return, the company’s deteriorating fundamentals and high leverage have raised concerns among analysts, prompting a cautious stance on the hospital sector player.

Read full news article

Healthcare Global Enterprises Ltd Downgraded as Quality Parameters Deteriorate

2026-02-02 08:00:35

Healthcare Global Enterprises Ltd, a key player in the hospital sector, has seen its quality grading downgraded from average to below average, reflecting a notable deterioration in its business fundamentals. Despite impressive long-term returns, recent financial metrics and leverage ratios have raised concerns among analysts, prompting a downgrade to a Sell rating with a Mojo Score of 44.0 as of 1 February 2026.

Read full news article

Healthcare Global Enterprises Ltd is Rated Hold

2026-01-29 10:10:47

Healthcare Global Enterprises Ltd is rated 'Hold' by MarketsMOJO, a rating that was last updated on 24 November 2025. While this rating change occurred several weeks ago, the analysis and financial metrics discussed here reflect the stock’s current position as of 29 January 2026, providing investors with an up-to-date perspective on the company’s standing.

Read full news article

Healthcare Global Enterprises Ltd is Rated Hold

2026-01-07 10:10:39

Healthcare Global Enterprises Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 24 Nov 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 07 January 2026, providing investors with an up-to-date view of its fundamentals, returns, and overall outlook.

Read full news article

Healthcare Global Enterprises Ltd is Rated Hold

2025-12-27 10:10:04

Healthcare Global Enterprises Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 24 November 2025. However, the analysis and financial metrics presented here reflect the stock's current position as of 27 December 2025, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Read full news article